US Broker Ratings

Pfizer, Inc. (PFE) Investor Outlook: Analyzing a Promising 15.64% Potential Upside

Pfizer Inc. (NYSE: PFE), a stalwart in the healthcare sector, offers a compelling narrative for investors seeking stability combined with growth potential. With a market capitalization of $142.37 billion, Pfizer..

Veeva Systems Inc. (VEEV) Stock Analysis: Navigating a 29.78% Potential Upside in the Healthcare Software Sector

Veeva Systems Inc. (NYSE: VEEV), a leading provider of cloud-based solutions for the life sciences industry, presents a compelling investment opportunity with a notable potential upside of 29.78%. With a..

CVS Health Corporation (CVS) Stock Analysis: Evaluating a 17.24% Potential Upside Amid Strong Buy Ratings

CVS Health Corporation (NYSE: CVS) stands as a formidable player in the healthcare sector, a segment increasingly critical in today’s evolving market landscape. With a robust market capitalization of $99.05..

GSK plc (GSK) Stock Analysis: Evaluating the Healthcare Giant’s Modest Upside Potential

GSK plc (NYSE: GSK), a prominent name in the healthcare sector, has drawn investor attention with its robust portfolio in vaccines and specialty medicines. Despite its storied history, dating back..

Stryker Corporation (SYK) Stock Analysis: Exploring a 16.48% Potential Upside and Strong Revenue Growth

Stryker Corporation (NYSE: SYK), a stalwart in the healthcare sector, commands attention with its robust market capitalization of $140.84 billion. As a leading player in the medical devices industry, Stryker’s..

UnitedHealth Group (UNH) Stock Analysis: Exploring a 20.86% Potential Upside for Investors

UnitedHealth Group Incorporated (NYSE: UNH) is a formidable player in the healthcare sector, with a market capitalization of $289.84 billion. Operating across a broad spectrum of healthcare services, this Minnesota-based..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating the Healthcare Giant’s Growth and Dividend Potential

Johnson & Johnson (JNJ) stands as a towering figure in the healthcare sector, commanding a market capitalization of $491.26 billion. With a diverse portfolio spanning pharmaceuticals, medical devices, and consumer..

Kamada Ltd. (KMDA) Investor Outlook: A 120% Upside Potential Beckons in the Biopharma Sector

For investors keen on exploring opportunities within the healthcare sector, Kamada Ltd. (NASDAQ: KMDA) presents an intriguing proposition. Specializing in the manufacture and sale of plasma-derived protein therapeutics, the Israel-based..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: A Potential 91.81% Upside in the Biotech Sector

For investors with an appetite for high-risk, high-reward opportunities, Rapport Therapeutics, Inc. (NASDAQ: RAPP) presents an intriguing case within the biotechnology sector. With a market capitalization of $1.28 billion, this..

AngioDynamics, Inc. (ANGO) Stock Analysis: A 62% Upside Potential for Healthcare Investors

AngioDynamics, Inc. (ANGO) presents a compelling case for investors with a robust target price range and a significant potential upside. Based in Latham, New York, this medical technology company specializes..

Standard BioTools Inc. (LAB) Stock Analysis: Exploring a 21% Upside Potential Amidst Challenging Financial Metrics

Standard BioTools Inc. (NASDAQ: LAB), a player in the healthcare sector specializing in medical devices, has garnered attention with a potential upside of 21.09% according to analyst ratings. Despite current..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: A Potential 73% Upside in the Biotech Sector

Oric Pharmaceuticals, Inc. (ORIC), a burgeoning player in the biotechnology industry, is capturing investor attention with its innovative approach to tackling cancer resistance mechanisms. Headquartered in South San Francisco, California,..

Emergent BioSolutions Inc. (EBS): Analyst Ratings Signal 48.68% Upside Potential

Emergent BioSolutions Inc. (NYSE: EBS), a prominent player in the healthcare sector, presents an intriguing opportunity for investors with a potential upside of nearly 49% based on current analyst ratings...

Inventiva S.A. (IVA) Stock Analysis: A Promising 302.71% Potential Upside for Biotech Enthusiasts

Biotechnology investors with a keen eye for growth opportunities may find Inventiva S.A. – American Depositary Shares (IVA) an intriguing prospect. As a clinical-stage biopharmaceutical company headquartered in Daix, France,..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Strong Buy Ratings Amid a Promising 12.86% Upside Potential

Maze Therapeutics, Inc. (NASDAQ: MAZE), a burgeoning force in the biotechnology sector, is catching the eyes of investors with its promising pipeline and robust analyst support. With the stock currently..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Evaluating Revenue Growth Amidst Valuation Challenges

Sonida Senior Living, Inc. (SNDA) is a notable player in the healthcare sector, specifically within the medical care facilities industry in the United States. With a market capitalization of $600.83..

Precigen, Inc. (PGEN) Stock Analysis: Unveiling a Potential 117.95% Upside in the Biotech Sector

Precigen, Inc. (NASDAQ: PGEN) is catching the attention of investors with its impressive potential upside of nearly 118%, according to analyst ratings. This biotechnology company, specializing in gene and cell..

Upstream Bio, Inc. (UPB) Stock Analysis: Unveiling a 91.51% Potential Upside in the Biotech Sector

Upstream Bio, Inc. (NASDAQ: UPB) is making waves in the biotechnology sector with its promising clinical-stage developments and significant market potential. Headquartered in Waltham, Massachusetts, this innovative company focuses on..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a 35% Upside Potential in Biotechnology

Theravance Biopharma, Inc. (NASDAQ: TBPH) presents an intriguing opportunity for savvy investors with its promising potential upside of 35.01%, as indicated by the average target price of $24.17 against its..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Exploring a Potential 11.64% Upside in the Healthcare Sector

Fortrea Holdings Inc. (FTRE), a burgeoning player in the biotechnology industry, is attracting investor attention with its promising position within the healthcare sector. This Durham, North Carolina-based company is making..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds